| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10969712 | Vaccine | 2009 | 7 Pages |
Abstract
This large-scale analysis supports the good safety profile of (+)MF59 seasonal and pandemic influenza vaccines and suggests a clinical benefit over (â)MF59 influenza vaccines.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Michele Pellegrini, Uwe Nicolay, Kelly Lindert, Nicola Groth, Giovanni Della Cioppa,